§
* Department of Chemistry and Biochemistry, University of California at Los Angeles, Los Angeles, California 90095-1569; Program on Aging, The Burnham Institute, La Jolla, California 92037; and § Neuroscience Department, University of California
at San Diego, La Jolla, California 92093
We expressed the human anti-apoptotic protein, Bcl-2, in Saccharomyces cerevisiae to investigate
its effects on antioxidant protection and stationary
phase survival. Yeast lacking copper-zinc superoxide
dismutase (sod1) show a profound defect in entry
into and survival during stationary phase even under
conditions optimal for survival of wild-type strains (incubation in water after stationary phase is reached).
Expression of Bcl-2 in the sod1
strain caused a large
improvement in viability at entry into stationary phase, as well as increased resistance to 100% oxygen and increased catalase activity. In addition, Bcl-2 expression
reduced mutation frequency in both wild-type and
sod1
strains. In another set of experiments, wild-type
yeast incubated in expired minimal medium instead of water lost viability quickly; expression of Bcl-2 significantly delayed this stationary phase death. Our results
demonstrate that Bcl-2 has activities in yeast that are
similar to activities it is known to possess in mammalian
cells: (a) stimulation of antioxidant protection and (b)
delay of processes leading to cell death.
Bcl-2 is a human protein that was originally isolated
based on its oncogenic properties (37). Unlike
most carcinogens, which act by affecting cell proliferation, Bcl-2 acts by inhibiting cell death, but the precise mechanism of its action is unknown. Bcl-2 does appear to play an antioxidant role in some experimental systems, possibly by blocking the generation of oxygen
radical species that play a role in apoptotic or necrotic processes (16).
Apoptosis is a type of programmed cell death, or cell
suicide, in which a clearly defined and active pathway
leads to an orderly death. Apoptosis has defining morphologic features in mammalian cells, but programmed cell
death without some or all of these features occurs in some
lower organisms (4, 28, 31).
Oxidative damage can cause cell death by either apoptosis or necrosis, depending on the degree of the damage.
Expression of Bcl-2 in neuronal cells has been shown to
result in decreased generation of reactive oxygen species,
decreased lipid peroxidation, and decreased apoptosis
(19). It has also been shown that Bcl-2 can inhibit necrotic
death (death by catastrophe, which includes cell lysis and
uncontrolled spillage of contents), as well as apoptotic
death in mammalian neuronal cells (20). Bcl-2 was found
to protect mammalian cells from death due to other oxidative insults as well, such as hypoxia/glycemia, ionizing radiation, and hydrogen peroxide (16, 32). On the other hand,
it has recently been shown that Bcl-2 can inhibit oxygen-independent apoptosis (18, 33), suggesting that it can also
act in a paradigm that does not require oxygen.
The yeast Saccharomyces cerevisiae is a highly studied
unicellular eucaryote with some remarkable similarities to
human cells at the macromolecular and organelle level. A
number of yeast proteins, such as Ras (27) and superoxide
dismutase (29), have been shown to be functionally interchangeable with the highly homologous human proteins.
Furthermore, yeast can be easily manipulated genetically (12) and its genome has been completely sequenced (26);
these features make this simple eukaryote an excellent
host for study of the function of human proteins.
Yeast, like other eukaryotic cells, contain two unrelated
superoxide dismutases (SODs):1 a copper- and zinc-containing form (CuZnSOD, product of the SOD1 gene) in
the cytoplasm and a less abundant manganese containing form (MnSOD, product of the SOD2 gene) in the mitochondrial matrix. Yeast mutants lacking CuZnSOD (sod1 The growth cycle of a typical yeast culture in glucose
medium follows a distinct pattern. First, there is a phase of
logarithmic growth while cell density is relatively low and
glucose is fermented. When glucose is used up the cells undergo a shift to respiratory metabolism and growth slows.
Finally yeast enter stationary phase We previously studied Bcl-2 expressed in log phase
sod1 In the present paper, we describe our investigation of
the more dramatic effects of Bcl-2 expression on stationary phase yeast. The characteristic features of yeast in this
phase (use of respiration rather than glycolysis for energy,
lack of cell division, and prolonged survival time) make
cells in this phase a suitable model system for higher organisms. In addition, cell death can be studied in this stationary phase model system; it is thus particularly suitable
for studies of the effects of Bcl-2 expression since Bcl-2 exerts its effects in mammalian cells by preventing death rather than by promoting growth. Our goals for this study
were the following: (a) to determine if Bcl-2 functions as
an antioxidant in yeast; (b) to determine if Bcl-2 can block
cell death in a single-celled eukaryote; and (c) to define a
simple model system in which to study the mechanism of
action of Bcl-2. We report here our findings that Bcl-2 reverses growth and survival defects of yeast lacking superoxide dismutase and that it substantially improves survival
of wild-type S. cerevisiae under death-inducing conditions.
Yeast Strains
Strains of S. cerevisiae used in these studies are the following: EG103 (wild
type) (DBY746; MAT The expression of Bcl-2 was verified by Western analysis. A 25-µg sample of total cellular protein was run on a 15% SDS-polyacrylamide gel.
Purified human recombinant Bcl-2 was used as a control and Bcl-2 was detected by anti-Bcl-2 antibody (cat. # 1624 989; Boehringer Mannheim Biochemicals, Indianapolis, IN) using the Western-Light Plus Chemiluminescent Detection System (TROPIX, Inc., Bedford, MA). Bcl-2 antibody
(primary antibody) was diluted 1:80 and anti-rabbit alkaline phosphatase-
conjugated secondary antibody 1:10,000. In all cases where the bcl-2 gene
was present (and in no cases where the gene was not present), protein that
reacted with the anti-Bcl-2 antibody was detected.
Media and Growth Conditions
Unless stated otherwise, all experiments in liquid media were performed
in synthetic dextrose complete media (SDC) with 2% glucose, and supplemented with amino acids, adenine and uracil as described (18) as well as a
fourfold excess of the supplements Trp, Leu, His, and uracil. Strains were
streaked from frozen stocks onto YPD (1% yeast extract, 2% peptone,
2% dextrose, 2% agar) plates. After 3 d of incubation, cells from a single
colony on the YPD plates were transferred to 3 ml of SDC overnight medium lacking the appropriate supplement (Leu, ura, and/or Trp) to select for plasmid-containing cells (LEU+) with the correct SOD deletion
(URA+ for sod1 For experiments in 100% oxygen, cells were grown to stationary phase
and on day 3 viability was measured as described above, except that plates
were incubated for 48 h in glass dessicators filled with 100% oxygen, followed by incubation in air for the remainder of the time. The dessicator
containing the plates was filled by evacuating and refilling it with oxygen
two times. Alternatively, oxygen was gently blown in to the bottom of the
dessicator for 15 min, allowing gas to escape through a small hole in the
top. In either case, the container was then sealed and incubated at 30°C.
Oxygen was replenished after 24 h. Identical control platings were always
made and incubated in low oxygen (CampyPaks).
GSH Determination
Cells were grown as described above. At the desired time, 5 × 108 cells
were pelleted at 3,000 g and the supernatant was carefully removed. The
tubes were held on ice. 100 µl of 3.5% sulfosalicyclic acid and 100 µl of
glass beads (0.5 µm, acid washed and dried) were added. Cells were vortexed for 1 min and then placed on ice for 1 min. This vortexing/cooling
process was repeated six times. The samples were then centrifuged at
15,000 g for 3 min. The acid soluble fraction was used to determine glutathione concentration. Total glutathione was measured according to the
method of Tietze (36). Oxidized glutathione (GSSG) was measured using
the method of Griffith (11) in which 2-vinylpyridine was used to derivatize the reduced form of glutathione. Standard curves used in this assay contained all components used to derivatize the reduced form of the glutathione.
Enzyme Activities and Metal Ion Levels
Crude cellular protein extracts were prepared by glass bead lysis as follows. Cells were suspended in lysis buffer at 4°C (50 mM Tris 7.2, 150 mM
NaCl, 5 mM EDTA, and 0.2 mM PMSF) with an equal volume of acid
washed 0.5 mm glass beads, and vortexed for six to eight cycles of 30 s of
vortexing followed by 30 s of cooling. The mixture was then microfuged
for 2 min to remove the cellular debris and glass beads. The supernatant
was frozen until assayed. The catalase activity was determined spectrophotometrically by monitoring the disappearance of hydrogen peroxide at
240 nm (25). SOD activity was determined by monitoring inhibition of the
autoxidation of 6-hydroxydopamine (14, 15). Protein concentration was
determined using the Bio Rad assay (Bio Rad Laboratories, Hercules,
CA), with bovine serum albumin as protein standard.
Copper and manganese were determined by atomic absorption spectrophotometry, using a Varian SpectrAA (Varian Instr. Business, San
Fernando, CA) equipped with graphite furnace. Whole cell samples were
digested in 3% HNO3 at 100°C overnight, and then diluted to 0.1% HNO3
for analysis. Alternatively soluble protein extracts were made to 0.1%
HNO3 and incubated overnight before analysis.
Mutation Frequencies
Mutation frequency was estimated by determining the number of cells
able to form colonies on SDC plates lacking arginine and containing 60 µg/ml canavanine. (Resistance to canavanine, an arginine analogue, arises
when mutations in the arginine permease occur.) Approximately 100 million cells were removed from cultures after 72 h of incubation and plated
on canavanine plates. Colonies were counted after 4 d. Mutation frequencies are reported as mutants per 106 viable cells. Three separate experiments with duplicate platings of duplicate samples were performed.
Bcl-2 Reversed Viability Defects of sod1 To determine whether human Bcl-2 could overcome cell
death associated with oxidative stress, we expressed Bcl-2
in strains lacking either or both SODs. In the paradigm
used here (24), cells were grown to saturation in SDC medium. At 72 h, the cells were washed, resuspended in water, and the incubation continued. Under this treatment,
strains lacking either SOD are known to lose viability rapidly (24), beginning at entrance into stationary phase,
while wild-type cells survive up to 2 mo.
In the present study, sod1
Table I.
Long Term Viability of Strains Expressing Bcl-2
)
are in a chronic state of oxidative stress while they are
growing in air, are sensitive to hyperoxia, and are unable
to grow in the absence of methionine and lysine (8). Yeast
mutants lacking MnSOD (sod2
) have a less dramatic
phenotype when grown in standard glucose media, but are
sensitive to hyperoxia. The phenotype of the double mutant (sod1
sod2
) is a summation of the single mutant
phenotypes.
there is no further
growth, but they can survive for weeks without added nutrients, i.e., in water. Mutants lacking either SOD rapidly lose viability after reaching stationary phase, and reactive
oxygen species originating from the mitochondria have
been shown to play a major role in the death of these
strains (24).
yeast (deficient in CuZnSOD) and observed small
improvements in the oxygen-sensitive phenotype (19). Thus,
stationary phase in these strains, wherein yeast are dying
due to oxidative stress, seemed an ideal one in which to
study further the effects of Bcl-2 expression. While the
death we observed may not be apoptotic nor necessarily due to any other form of programmed cell death, it is
clearly a reproducible death pattern, and the effects we
observe may therefore provide insight into the mechanism
of Bcl-2 action.
Materials and Methods
leu2-3,112 his3
1 trp1-289 ura3-52 GAL+),
EG118 (sod1
) (EG103 with sod1
A::URA3), and EG133 (sod1
sod2
) (EG103 with sod1
A::URA3 sod2
::TRP1) (9, 23). In these strains the
mutations in SOD1 and SOD2 are deletions of most of the coding region.
In all the experiments reported in this paper, these strains were transformed with either plasmid pAD4, a multicopy yeast expression vector
carrying the LEU2 selectable marker, or pAD4-bcl-2, the same vector carrying the human bcl-2 gene under the transcriptional control of the strong
alcohol dehydrogenase (ADH1) promoter (19). Expression from this promoter is high during log phase growth and decreases at stationary phase.
Transformations were carried out by the lithium acetate method (17). It
should be pointed out that, as observed in our previous study (24), sod1
mutants transformed with plasmids lost viability somewhat less rapidly than untransformed mutants. This is a behavior that we have not yet explained, but which may be due to unavoidable selection for robustness
during the transformation, or to an effect of the LEU2 marker, which was
present in all the plasmids. To test the latter possibility, the experiments
described herein were repeated with strains transformed with the plasmids
pBMT116 (vector control) and pBMT116-bcl-2 (carrying human bcl-2
cDNA), which are similar to the pAD4 plasmids, except that they contain
the TRP1 selectable marker. Results with these plasmids (data not shown)
were similar to those reported in this paper using LEU2 plasmids.
or TRP+ for sod2
). For normal oxygen (high aeration)
conditions, overnight cultures grown in selective media were inoculated at
an OD600 of 0.01 into flasks with a flask volume/medium volume ratio of 5:
1 and grown at 30°C, shaking at 220 rpm. Growth was followed by monitoring the turbidity at 600 nm (OD600). An OD600 of 1 is equivalent to 107
cells per ml. For long-term stationary phase cultures, after 72 h, the cells
were washed twice, resuspended in sterile distilled water, and incubation
with shaking was continued. Cell viability was measured by plating serial
dilutions of the yeast cultures onto YPD plates. Colonies formed were
counted after 2 d of incubation at 30°C. Plates from cell lines lacking
CuZnSOD were incubated in a low oxygen atmosphere generated using
CampyPaks (BBL Scientific, Cockeysville, MD). All experiments were repeated at least three times with duplicate samples.
Results
and
sod1
sod2
Mutants
and sod1
sod2
mutants
transformed with either the multicopy plasmid pAD4-bcl-2
or the vector control pAD4, were tested for survival. Early
in the culture, when growth was logarithmic (early log
phase, <2 × 107 cells/ml) Bcl-2 had little effect on the viability (Fig. 1). At late log phase (~6 × 107 cells/ml, generally reached after 10-15 h of growth), differences began to
be apparent. By the time stationary phase was reached at
24 h (10-13 × 107 cells/ml, no further growth), differences
were quite obvious. At 24 h, sod1
and sod1
sod2
strains expressing Bcl-2 maintained their viability, while
the viability of strains carrying plasmid controls was markedly reduced (Fig. 1). Over a culture period of 26 d, viability for all strains continued to decrease and the strain expressing Bcl-2 continued to show a much higher survival rate than the control. Table I (first two columns) summarizes the survival of the sod1
and sod1
sod2
strains
with or without Bcl-2 expression at 26 d. Because of the
large difference in viability already evident at day 1 (Fig. 1)
we also show the data normalized to the viability on day 1 (Table I, last two columns). For the sod1
strain, the difference was statistically significant (P < 0.01 by the two-sided t test) in both cases (raw data as well as normalized).
The difference for the sod1
sod2
strain was not statistically significant, although the trend was always the same as
for the single sod1
mutant. Nevertheless, the major effect of Bcl-2 expression on survival in these experiments
clearly occurred at the time of entry into stationary phase,
rather than in the later stages.
Fig. 1.
Bcl-2 reversed stationary phase viability loss in strains
lacking one or both SODs. Percent viability of sod1 (EG118)
and sod1
sod2
(EG133) strains with or without Bcl-2 expression at different stages of growth. Data are reported as percent viable cells, or colony forming units (live cells), per total cells (live and dead cells). Total cell number was determined by optical
density (OD600) and confirmed by hemocytometer counting. Differences between control and Bcl-2-expressing strains at 24 h are
significant (P < 0.01). (white bars) sod1
; (gray bars) sod1
-
sod2
; (crosshatched pattern) strains expressing Bcl-2; (no pattern) strains harboring plasmid vector (pAD4).
[View Larger Version of this Image (55K GIF file)]
Bcl-2 Improved Survival of sod1 Mutants in
100% Oxygen
Somewhat surprisingly, wild-type yeast with or without
Bcl-2 expression grew well in 100% oxygen, exhibiting 80-
100% viability relative to growth in air (data not shown).
On the other hand, yeast lacking CuZnSOD and/or MnSOD
were quite sensitive to 100% oxygen and were unable to
form colonies under these conditions. To test the effect of
Bcl-2 expression on the growth of sod1, sod2
, and
sod1
sod2
mutants under this intense oxidative stress, we tested the ability of these strains to survive a 48 h exposure to 100% oxygen. As shown in Fig. 2, expression of
Bcl-2 in SOD-deficient cells substantially improved their
ability to form colonies after incubation in 100% oxygen.
The effect was particularly pronounced for the sod1
single mutant, but was also evident for the sod2
single mutant and the double mutant.
Effects of Bcl-2 Are Not Due to Altered Copper or Manganese Metabolism
Culotta and co-workers (21) have recently identified
several mutations that partially "rescue" the sod1 sod2
strain, and they showed that each of these mutations altered copper or manganese metabolism in some way. One
of these, the pmr1 mutation, exerted its effects by increasing cellular manganese accumulation. (High intracellular
manganese was previously shown to rescue sod1
mutants, probably by its own dismutase activity [2].) A side
effect of the pmr1 mutation is an increased sensitivity to
abnormally high manganese levels in the medium (21). We
reasoned that, if Bcl-2 exerted its effects by a mechanism
similar to that of pmr1, we should see increased sensitivity
to manganese and increased manganese accumulation in
strains expressing Bcl-2. In fact, we saw the opposite, expression of Bcl-2 in strains lacking SOD led to decreased sensitivity to elevated manganese levels as measured by
cell survival (Fig. 3 A) and decreased manganese accumulation as measured by atomic absorption (Fig. 3 B). In other
words, Bcl-2 expression caused the sod1
and sod1
sod2
strains to exhibit a more wild-type-like phenotype.
Culotta and co-workers also observed that a mutation in
the yeast BSD2 gene bypassed the growth requirement for
SOD by altering copper homeostasis in a manner seemingly analogous to the pmr1 mutation. In this case, cells
became hypersensitive to elevated copper concentrations
(22). We tested sod1 and sod1
sod2
strains expressing
Bcl-2 for copper sensitivity and saw a slight, although not
statistically significant, decrease in sensitivity in the Bcl-2
expressors (data not shown). This decrease came instead of the marked increase we would have expected if Bcl-2
were working through a mechanism like that of bsd2. We
conclude that, unlike other suppressors of the sod1
phenotype, Bcl-2 does not work via effects on copper or manganese accumulation.
Indices of Antioxidant Protection in Cells Expressing Bcl-2
To determine if Bcl-2 had a direct effect on the status of
other antioxidant proteins in yeast, we measured catalase
activity in both wild-type and sod1 mutant cells expressing Bcl-2 (Fig. 4). Yeast has two catalases (Catalase A and
Catalase T), but only the cytoplasmic Catalase T is expressed under our conditions. Catalase A is peroxisomal
and only expressed under special conditions (8). We observed an increase in catalase activity for wild-type cells
expressing Bcl-2 relative to vector-transformed controls. The sod1
mutant had a lower level of catalase than wild
type. Bcl-2 expression caused an increase in catalase activity, but the activity was still lower than that of the wild-type strain (Fig. 4).
We also monitored levels of reduced and oxidized glutathione (GSH and GSSG, respectively) in wild-type cells with or without expression of Bcl-2. Total glutathione (GSH + GSSG) levels were unchanged by Bcl-2 expression, but the GSH:GSSG ratio increased from 85:1 for the vector-transformed control to 105:1 for the Bcl-2 expressor, indicating a slightly more reducing condition in the cells expressing Bcl-2. This result was significant to the P < 0.1 level.
Mutation Frequencies Increased in sod1 and
sod1
sod2
Mutants Compared to Wild Type, but
Decreased in Yeast Expressing Bcl-2
Steinman reported that expression of Bcl-2 in Escherichia
coli led to increased catalase expression and a higher mutation rate, and he therefore proposed a pro-oxidant mechanism for Bcl-2 in this system (33). To determine whether
a similar phenomenon occurred in yeast expressing Bcl-2,
we measured mutation frequencies, using forward mutation to canavanine resistance. As expected based on earlier work (9), mutation frequencies were clearly higher in
sod1 and sod1
sod2
mutants than in the wild-type parental strain. However, in all three cell lines, Bcl-2 expression decreased mutation frequencies (Table II). This result
is consistent with an antioxidant activity for Bcl-2, since
oxidative damage is believed to be the cause of much
spontaneous mutation and is almost certain to be the
cause of the excess spontaneous mutation found in strains lacking CuZnSOD.
Table II. Mutation Rates |
Bcl-2 Prolonged Wild-Type Yeast Survival in Spent Medium
We recently observed that yeast cells left in expired synthetic glucose medium (SDC), but not in rich medium
(YPD) or water, lost viability quickly (Longo, V.D., P. Morcos, T.E. Johnson, E.B. Gralla, and J.S. Valentine, manuscript submitted for publication). To determine whether
Bcl-2 could affect this type of cell death, we studied survival in water and in expired SDC medium of wild-type yeast expressing Bcl-2. Wild-type yeast left in complete
glucose medium (SDC) rapidly lost viability beginning at
day 5. The viability loss was significantly delayed by expression of Bcl-2 such that there was a five- to sixfold difference in the number of survivors by day 10 (Fig. 5). To
be sure that the viability loss was not caused by the nutritional auxotrophies of the EG103 wild-type strain, survival
in spent medium was also measured for the prototrophic strains D27310b, which also lost viability prematurely
(data not shown). By contrast, no effect of Bcl-2 was seen
on survival of wild-type yeast under conditions optimal for
stationary phase survival, i.e., switched to water at day 3, probably because survival was already very high (Fig. 5).
The yeast sod1 and sod1
sod2
strains provide a simple
model system for studies of the properties of Bcl-2. The
presence of Bcl-2 prevented short-term death of both
yeast sod1
and sod1
sod2
mutants at the point of entry
into stationary phase (Fig. 1). In addition, it improved, although less dramatically, their long-term survival (Table II).
Furthermore, Bcl-2 enabled sod1
, but not sod1
sod2
,
mutants to grow in 100% oxygen (Fig. 2) and increased indicators of antioxidant defense, i.e., catalase (Fig. 4) and
reduced glutathione. These results confirm an antioxidant property for Bcl-2 and suggest that it functions in this regard by acting on basic intracellular mechanisms present
in all eukaryotes (in human cells as well as in yeast).
Mechanisms of oxidative stress and antioxidant defenses
in vivo are intimately connected with metal metabolism.
Most pathways that have been proposed for generation of
significant fluxes of reactive oxygen species in vivo involve
participation of redox active metal ion catalysts (usually
copper or iron ions). Defensive mechanisms also often involve metal ions, e.g., superoxide dismutase and catalase
are metalloenzymes. Studies on sod1 yeast have demonstrated the importance of metal ions in oxidative stress resistance. First, high levels of extracellular manganese ion
rescued sod1
strains, apparently because excess manganese accumulated in the cytoplasm and was able to function as a weak dismutase (2). In addition, sod1
strains
have been shown to be partially rescued by excess copper
in the medium. This rescue depended upon intracellular binding of the metal by the yeast copper metallothionein
protein (34), rather than on a "free" metal ion as is postulated for manganese, but is otherwise similar.
Thus far, all mutations identified that reverse growth defects of sod1 and sod1
sod2
yeast appear to cause accumulation of manganese or copper in the cytosol. If Bcl-2
were involved in the accumulation of manganese or copper, as are the products of the PMR1 and BSD2 genes, respectively (21, 22), we would have expected a higher sensitivity to elevated concentrations of these metal ions in
cells expressing the oncoprotein. We found instead that
Bcl-2 improves the growth of sod1
and sod1
sod2
mutants in the presence of both metals but especially manganese (Fig. 3), indicating that it works in another fashion.
We have not yet determined whether this improvement is
due to a general decrease of the oxidative stress in the cells
or to a direct involvement of Bcl-2 in manganese homeostasis or subcellular distribution.
Mammalian neural cells expressing Bcl-2 have recently been shown to contain increased concentrations of glutathione (5, 19). The expression of Bcl-2 in E. coli was shown to induce catalase expression without exposure to exogenous hydrogen peroxide. It also led to increased mutation rates, leading the author to conclude that this oncoprotein functions as a prooxidant (33). In yeast, we also observed an increase in catalase activity in strains expressing Bcl-2 (Fig. 4), but the spontaneous mutation frequency was reduced by Bcl-2 expression (Table II). In addition, wild-type yeast expressing Bcl-2 had slightly higher GSH/ GSSG ratios than wild-type controls, although no difference in total glutathione was observed. Taken together, these data argue against a prooxidant effect of this oncoprotein in yeast and support a role for Bcl-2 in promoting antioxidant defenses.
We observed that wild-type yeast kept in expired SDC
medium (not switched to water) during stationary phase
lost viability rapidly. While the death of sod1 and sod1
-
sod2
strains is known to be oxidative (24) it is not clear to
what to attribute the death of wild-type cells in expired
medium. The death of wild-type cells in expired medium
was delayed by the expression of human Bcl-2 (Fig. 5).
The precipitous viability loss we observed for yeast in expired minimal medium was quite surprising, especially in
view of the fact that yeast transferred to water show no
such dramatic viability loss and instead survive for months.
A possible explanation is based on the assumption that
yeast are likely to encounter a nutrient-depleted environment quite often in the wild and therefore might be expected to recognize and respond to such a condition. It is
thus possible that death could be an evolved response to
such a situation. One's first notion is that in a unicellular
organism such as yeast, each individual cell competes against all others. However, this approach may not be the
most effective for maintenance of the species. Yeast grow
in colonies that are generally isogenic, so survival of the
genes of a single colony is guaranteed even if only a few
organisms survive. The cell death we observed in expired
medium could be explained by a specific cell suicide program, evolved to kill most members of a colony so that a
few better-adapted individuals could survive and grow on
the limited nutrients. This putative death program would
increase the chance of survival of the species. The better adaptation of the lucky individual(s) that survived could
be due either to mutations (leading to natural selection) or
simply to random variation in the micro-environment. (Note
that such a suicide response would not be expected to
occur in pure water. Since there are no nutrients to be
shared, the best response is for each cell to last as long as
possible.)
Ras2 is one of two yeast Ras proteins that play roles in growth control and have structural and functional homology to the ras family of mammalian proto-oncogenes. In yeast, Ras is coupled to a signal cascade that involves intracellular cAMP and is sensitive to nutritional status (7, 35). In another study, we found that the viability loss of yeast in expired minimal medium was prevented by a null mutation in ras2, suggesting that Ras2 is involved in a cell death pathway (Longo, V.D., P. Morcos, T.E. Johnson, E.B. Gralla, and J.S. Valentine, manuscript submitted for publication). Interestingly, extracellular cAMP and starvation are involved in initiating the cell death program of stalk cells in the developmental cycle of the primitive eukaryote Dictyostelium (4). In human cells, Bcl-2 has been shown to co-precipitate with both R-Ras and p21-Ras (3, 6) both of which are highly homologous to yeast Ras2 (7). These observations raise the possibility that Bcl-2 may prevent cell death in yeast by acting through the Ras pathway.
Evidence is slowly accumulating that some lower eukaryotes, even unicellular ones, exhibit programmed cell death, which, however, may or may not share the morphological features that define apoptotic cell death (1). For example, a cell death program was demonstrated in E. coli, consisting of a plasmid-encoded DNA restriction/modification system that caused DNA cuts but not other typical apoptotic morphologies (28). Cell death during stalk formation in Dictyostelium followed a distinct program that included chromatin condensation, but not DNA fragmentation (4). Other, nonapoptotic forms of PCD may occur in higher eukaryotes as well. For example, none of the features characteristic of apoptosis were observed in the PCD of intersegmental muscle of the moth Manduca sexta at the end of metamorphosis (31).
The results presented here are consistent with the presence of a programmed cell death pathway in yeast, but they are equally consistent with an antioxidant role for Bcl-2 which could be acting on pathways or proteins that promote compensatory antioxidant defenses in sod null mutants as well as wild-type cells under certain circumstances. Our searches of the yeast whole genome database did not reveal the presence of homologues of pro-apoptotic proteins such as ICE or CED-3, suggesting that a programmed cell death in yeast, if it does indeed exist, may not involve the proteins and mechanisms that cause apoptosis in higher eukaryotes. No Bcl-2 homologues with high identity were found either, but we cannot exclude the possibility that functional rather than sequence homologues of Bcl-2 may be present in yeast, or that bcl-2 is a relatively new feature of apoptosis, added later in evolution.
There are only a few reports in the literature examining members of the bcl-2 gene family expressed in yeast (10, 13, 30). These papers are based on the finding that expression of Bax, a cell death-inducing Bcl-2 family member, is toxic to yeast. Using the two-hybrid system, Reed and co-workers (13, 30) showed that this Bax-induced cell death was inhibited by co-expression of Bcl-2 and some Bcl-2 homologues which are known to interact physically with Bax. However, since expression of foreign proteins fairly frequently causes cell death, it is not clear in these studies whether the death observed is a specific triggered cell death pathway or simply the result of a non-specific toxicity. If the latter is the case, then rescue by Bcl-2 could be explained simply as a case of Bcl-2/Bax dimerization masking the toxicity. Our results demonstrate an antideath activity for Bcl-2 in yeast in the absence of Bax, increasing the possibility that a real cell death program is being observed.
Recent work (10) using a similar system, demonstrated
that Bax-related growth inhibition could be experimentally separated from cellular death in S. cerevisiae and that
the presence of functional mitochondria was necessary for
cell death to occur. These results make it appear more
likely that Bax is acting on an endogenous system. In our
work, both the oxidative stress-related death of sod1 and
sod1
sod2
mutants in stationary phase and the death of
wild-type cells in expired minimal medium occurred without introduction of any foreign genes, i.e., they are naturally occurring processes. That Bcl-2 is able to prevent
both kinds of death is therefore strong evidence that it is
acting on, or in concert with, an endogenous pathway that
already exists in yeast.
In conclusion, our results demonstrate that Bcl-2 can provide antioxidant protection in yeast and that it can delay natural death in two separate paradigms. The fact that Bcl-2 exerts an antioxidant-type protective effect in yeast is evidence supporting the centrality of this role. However, it is important to stress that the mechanism by which the antioxidant protection occurs and the connection between the antideath and antioxidant actions of Bcl-2 in our system, as well as in mammalian cells, remains unknown.
Received for publication 18 September 1996 and in revised form 27 February 1997.
1. Abbreviations used in this paper: SDC, synthetic dextrose complete medium; SOD, superoxide dismutase; YPD, yeast extract/peptone/dextrose.This work was supported by National Institutes of Health grants DK46828 (to J.S. Valentine), AG12282, (to D.E. Bredesen), NS25554, (to D.E. Bredesen), and a pilot research grant from the University of California at Los Angeles Center on Aging based on a generous gift to the center by Harold and Libby Ziff (to J.S. Valentine and E.B. Gralla).
1. | Ameisen, J.C.. 1996. The origin of programmed cell death. Science (Wash. DC). 272: 1278-1279 |
2. |
Chang, E.C., and
D.J. Kosman.
1989.
Intracellular Mn (II)-associated superoxide scavenging activity protects Cu,Zn superoxide dismutase-deficient Saccharomyces cerevisiae against dioxygen stress.
J. Biol. Chem.
264:
12172-12178
|
3. |
Chen, C.Y., and
D.V. Faller.
1996.
Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis.
J. Biol. Chem.
271:
2376-2379
|
4. |
Cornillon, S.,
C. Foa,
J. Davoust,
N. Buonavista,
J.D. Gross, and
P. Golstein.
1994.
Programmed cell death in Dictyostelium.
J. Cell Sci.
107:
2691-2704
|
5. | Ellerby, L.M., H.M. Ellerby, S.M. Park, A.L. Holleran, A.N. Murphy, G. Fiskum, D.J. Kane, M.P. Testa, C. Kayalar, and D.E. Bredesen. 1996. Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67: 1259-1267 |
6. | Fernandez-Sarabia, M.J., and J.R. Bischoff. 1993. Bcl-2 associates with the ras-related protein R-ras p23. Nature (Lond.). 366: 274-275 |
7. |
Gibbs, J.B., and
M.S. Marshall.
1989.
The ras oncogene![]() |
8. | Gralla, E.B., and D. Kosman. 1992. Molecular genetics of superoxide dismutases in yeasts and related fungi. Adv. Genet. 30: 251-319 |
9. | Gralla, E.B., and J.S. Valentine. 1991. Null mutants of Saccharomyces cerevisiae Cu,Zn superoxide dismutase: characterization and spontaneous mutation rates. J. Bacteriol. 173: 5918-5920 |
10. | Greenhalf, W., C. Stephan, and B. Chandhuri. 1996. Role of mitochondria and C-terminal membrane anchor of Bcl-2 in Bax induced growth arrest and mortality in S. cerevisiae. FEBS Lett. 380: 169-175 |
11. | Griffith, O.W.. 1980. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinyl pyridine. Anal. Biochem. 106: 207-212 |
12. | Guthrie, C., and G.R. Fink. 1991. Guide to Yeast Genetics and Molecular Biology. Methods in Enzymology (Vol. 194). J.N. Abelson and M.I. Simon, editors. Academic Press, Inc., San Diego, CA. 931 pp. |
13. |
Hanada, M.,
C. Aimé-Sempé,
T. Sato, and
J.C. Reed.
1995.
Structure-function analysis of Bcl-2 Protein.
J. Biol. Chem.
270:
11962-11969
|
14. | Heikkila, R.E. 1985. Autoxidation of 6-hydroxydopamine. In CRC Handbook of Methods for Oxygen Radical Research. R.A. Greenwald, editor. CRC Press, Boca Raton, FL. 233-235. |
15. | Heikkila, R.E., and C. Felicitas. 1976. A sensitive assay for superoxide dismutase based on the autoxidation of 6-hydroxydopamine. Anal. Biochem. 75: 356-362 |
16. | Hockenbery, D.M., Z.N. Oltvai, X.-M. Yin, C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75: 241-251 |
17. | Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153: 163-168 |
18. | Kaiser, C., S. Michaelis, and A. Mitchell. 1994. Methods in Yeast Genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 234 pp. |
19. | Kane, D.J., T.A. Sarafian, R. Anton, H. Hahn, E.B. Gralla, J.S. Valentine, T. Ord, and D.E. Bredesen. 1993. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science (Wash. DC). 262: 1274-1277 |
20. | Kane, D.J., T. Ord, R. Anton, and D.E. Bredesen. 1995. Expression of Bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40: 269-275 |
21. | Lapinskas, P.J., K.W. Cunningham, X.F. Liu, G.R. Fink, and V.C. Culotta. 1995. Mutations in PMR1 suppress oxidative damage in yeast cells lacking superoxide dismutase. Mol. Cell. Biol. 15: 1382-1388 [Abstract]. |
22. | Liu, X.F., and V.C. Culotta. 1994. The requirement for yeast superoxide dismutase is bypassed through mutations in BSD2, a novel metal homeostasis gene. Mol. Cell. Biol. 14: 7037-7045 [Abstract]. |
23. |
Liu, X.F.,
I. Elashvili,
E.B. Gralla,
J.S. Valentine,
P. Lapinskas, and
V.C. Culotta.
1992.
Yeast lacking superoxide dismutase![]() |
24. |
Longo, V.D.,
E.B. Gralla, and
J.S. Valentine.
1996.
Superoxide dismutase
activity is essential for stationary phase survival in Saccharomyces cerevisiae: mitochondrial production of toxic oxygen species in vivo.
J. Biol.
Chem.
271:
12275-12280
|
25. | Luck, H. 1965. Catalase. In Methods of Enzymatic Analysis. H.U. Bergmeyer, editor. Verlag Chemie Press, Berlin. 885-892. |
26. | MIPS. 1996. Saccharomyces genome data base. Martinsried Institute for Protein Sequences. Available via http://speedy.mips.biochem.mpg.de/mips/yeast, or . |
27. | Morishita, T., H. Mitsuzawa, M. Nakafuku, S. Nakamura, S. Hattori, and Y. Anraku. 1995. Requirement of Saccharomyces cerevisiae Ras for completion of mitosis. Science (Wash. DC). 270: 1213-1215 [Abstract]. |
28. | Naito, T., K. Kusano, and I. Kobayashi. 1995. Selfish behavior of restriction-modification systems. Science (Wash. DC). 267: 897-899 |
29. |
Rabizadeh, S.,
E.B. Gralla,
D.R. Borchelt,
R. Gwinn,
J.S. Valentine,
S. Sisodia,
P. Wong,
M. Lee,
H. Hahn, and
D.E. Bredesen.
1995.
Mutations
associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene![]() |
30. |
Sato, T.,
M. Hanada,
S. Bodrug,
S. Irie,
N. Iwama,
L.H. Boise,
C.B. Thompson,
E. Golemis,
L. Fong,
H.-G. Wang, and
J.C. Reed.
1994.
Interactions
among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system.
Proc. Natl. Acad. Sci. USA.
91:
9238-9242
|
31. | Schwartz, L.M., S.W. Smith, M.E. Jones, and B.A. Osborne. 1993. Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA. 90: 980-984 [Abstract]. |
32. | Shimizu, S., Y. Eguchi, H. Kosaka, W. Kamilke, H. Matsuda, and Y. Tsujimoto. 1995. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (Lond.). 374: 811-813 |
33. |
Steinman, H.M..
1995.
The Bcl-2 oncoprotein functions as a pro-oxidant.
J.
Biol. Chem.
270:
3487-3490
|
34. |
Tamai, K.T.,
E.B. Gralla,
L.M. Ellerby,
J.S. Valentine, and
D.J. Thiele.
1993.
Yeast and mammalian metallothioneins functionally substitute for
yeast copper-zinc superoxide dismutase.
Proc. Natl. Acad. Sci. USA.
90:
8013-8017
|
35. | Tatchell, K.. 1986. RAS genes and growth control in Saccharomyces cerevisiae. J. Bacteriol. 166: 364-367 |
36. | Tietze, F.. 1969. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27: 502-522 |
37. | Tsujimoto, Y., and C.M. Croce. 1986. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA. 83: 5214-5218 [Abstract]. |